Diffuse unilateral subacute neuroretinitis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Diffuse unilateral subacute neuroretinitis | |
|---|---|
| File:Diffuse unilateral subacute neuroretinitis.jpg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Vision loss, floaters, photopsia |
| Complications | Retinal detachment, permanent vision loss |
| Onset | Typically in young adults |
| Duration | Chronic |
| Types | N/A |
| Causes | Parasitic infection (e.g., nematodes) |
| Risks | Exposure to infected animals or contaminated soil |
| Diagnosis | Ophthalmic examination, visual field testing, serology |
| Differential diagnosis | Retinal detachment, uveitis, optic neuritis |
| Prevention | N/A |
| Treatment | Anti-parasitic medication, laser photocoagulation |
| Medication | N/A |
| Prognosis | Variable; early treatment can prevent severe vision loss |
| Frequency | Rare |
| Deaths | N/A |
Diffuse Unilateral Subacute Neuroretinitis (DUSN) is a rare ocular disease, primarily affecting the eye's retina and optic nerve. It is characterized by the presence of a parasitic infection, often caused by nematodes such as Toxocara canis or Baylisascaris procyonis. The condition is unilateral, affecting only one eye in most cases, and progresses subacutely, indicating a somewhat rapid development of symptoms over weeks to months.
Symptoms and Diagnosis[edit]
The initial symptoms of DUSN can be subtle and may include visual impairment, floaters, and scotoma (blind spots). As the disease progresses, more severe symptoms such as vitritis (inflammation of the vitreous body of the eye), papillitis (inflammation of the optic disc), and retinal vasculitis (inflammation of the retinal vessels) can develop. The diagnosis of DUSN is primarily clinical, based on the observation of the characteristic lesions in the retina and the presence of a motile subretinal nematode. Ancillary tests, including fluorescein angiography and optical coherence tomography (OCT), can aid in the diagnosis by revealing the extent of retinal and optic nerve damage.
Treatment[edit]
Treatment of DUSN is challenging and focuses on eliminating the parasitic infection and controlling the inflammatory response in the eye. Anti-parasitic medications, such as albendazole or ivermectin, are commonly used to target the nematode. Additionally, corticosteroids may be administered to reduce inflammation. In some cases, laser photocoagulation therapy is employed to directly target and destroy the nematode within the retina. Early diagnosis and treatment are crucial to prevent permanent visual impairment or blindness.
Epidemiology[edit]
DUSN is most commonly reported in tropical and subtropical regions, where the prevalence of the causative nematodes is higher. However, cases have been reported worldwide, indicating a global distribution. The disease predominantly affects children and young adults, but it can occur at any age. There is no known gender predilection.
Prevention[edit]
Prevention of DUSN involves controlling the spread of the causative nematodes, primarily through public health measures aimed at reducing human contact with contaminated soil and feces, which are common sources of nematode eggs. Regular deworming of pets, especially dogs, can also reduce the risk of transmission of Toxocara canis to humans.
Summary[edit]
Diffuse Unilateral Subacute Neuroretinitis is a serious ocular condition that can lead to significant visual impairment if not promptly diagnosed and treated. Awareness of the disease, particularly in endemic areas, and early intervention are key to preventing long-term visual sequelae.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian